EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasenkam, J. M.
Right arrow Articles by Pilegaard, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasenkam, J. M.
Right arrow Articles by Pilegaard, H. K.

European Journal of Cardio-Thoracic Surgery, Vol 11, 935-942, Copyright © 1997 by European Association for Cardio-thoracic Surgery


ARTICLES

Self management of oral anticoagulant therapy after heart valve replacement

JM Hasenkam, HH Kimose, L Knudsen, H Gronnesby, J Halborg, TD Christensen, J Attermann and HK Pilegaard
Department of Cardiothoracic and Vascular Surgery, Skejby Sygehus, Aarhus University Hospital, Aarhus N, Denmark. skejmh@aau.dk

OBJECTIVE: Patients with mechanical heart valves require lifelong oral anticoagulant treatment which entails frequent blood sampling and dosage adjustment. The purpose of this study was to investigate the feasibility of letting heart valve operated patients manage blood specimen analysis and dosage adjustment themselves. METHODS: A total of 21 patients were enrolled in the study and followed for at least 9 months postoperatively. Immediately after the heart valve operation they were trained in operating a CoaguChek international normal ratio (INR) monitor to analyze capillary whole blood samples. Subsequently training in dosage adjustment was accomplished and all patients were considered fully capable of self management after 30 weeks. In the training period, parallel laboratory INR measurements were made at 3-4 week intervals for reference. A control group of 20 patients was matched, respectively, to the study group. The INR target range was 2.0- 3.0. RESULTS: Out of the 21 study patients 19 continued self management beyond 9 months. The median INR value obtained with the monitor was within therapeutic target range for all study patients and only 15 out of 20 control patients were within this range. The mean systematic deviation between laboratory and CoaguChek INR was 7.8% but each patient had a constant characteristic deviation from -11 to +21%. The study patients were within therapeutic target range 77% of the time compared with 53% for the control patients. CONCLUSIONS: Self management of oral anticoagulation is feasible for selected patients and constitutes a significant service improvement compared with conventional management. The CoaguChek monitor seems sufficiently accurate and reliable for self testing and the treatment quality is comparable or even better than conventional management. Assessment of the rate of bleeding and thrombo-embolic events shall be settled in studies comprising larger number of patients.


This article has been cited by other articles:


Home page
CMAJHome page
N. Oake MSc, A. Jennings MA, A. J. Forster MD MSc, D. Fergusson PhD, S. Doucette MSc, and C. van Walraven MD MSc
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis
Can. Med. Assoc. J., July 29, 2008; 179(3): 235 - 244.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
N. Oake, D. A. Fergusson, A. J. Forster, and C. van Walraven
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis
Can. Med. Assoc. J., May 22, 2007; 176(11): 1589 - 1594.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
D. A. Regier, R. Sunderji, L. D. Lynd, K. Gin, and C. A. Marra
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.
Can. Med. Assoc. J., June 20, 2006; 174(13): 1847 - 1852.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. van Walraven, A. Jennings, N. Oake, D. Fergusson, and A. J. Forster
Effect of Study Setting on Anticoagulation Control: A Systematic Review and Metaregression
Chest, May 1, 2006; 129(5): 1155 - 1166.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D A Fitzmaurice, E T Murray, D McCahon, R Holder, J P Raftery, S Hussain, H Sandhar, and F D R Hobbs
Self management of oral anticoagulation: randomised trial
BMJ, November 5, 2005; 331(7524): 1057.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
H. Voller
In defence of current treatment options: where are we now?
Eur. Heart J. Suppl., June 1, 2005; 7(suppl_E): E4 - E9.
[Full Text] [PDF]


Home page
ChestHome page
J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek
The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 204S - 233S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. N. Levine, G. Raskob, R. J. Beyth, C. Kearon, and S. Schulman
Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 287S - 310S.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. P. A. Gadisseur, W. G. M. Breukink-Engbers, F. J. M. van der Meer, A. M. H. van den Besselaar, A. Sturk, and F. R. Rosendaal
Comparison of the Quality of Oral Anticoagulant Therapy Through Patient Self-management and Management by Specialized Anticoagulation Clinics in the Netherlands: A Randomized Clinical Trial
Arch Intern Med, November 24, 2003; 163(21): 2639 - 2646.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Sidhu and S. W. MacGowan
Self-managed anticoagulation is safe and effective
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 668 - 668.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. D. Christensen, N. T. Andersen, J. Attermann, V. E. Hjortdal, M. Maegaard, and J. M. Hasenkam
Mechanical heart valve patients can manage oral anticoagulant therapy themselves
Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
D A Fitzmaurice, E T Murray, K M Gee, T F Allan, and F D R Hobbs
A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management
J. Clin. Pathol., November 1, 2002; 55(11): 845 - 849.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J.J.M. Takkenberg, J.P.A. Puvimanasinghe, L.A. van Herwerden, E.W. Steyerberg, M.J.C. Eijkemans, J.D.F Habbema, and A.J.J.C. Bogers
Prognosis after aortic valve replacement with St. Jude Medical bileaflet prostheses: impact on outcome of varying thromboembolic and bleeding hazards
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q27 - Q32.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
H. Voller, C. Dovifat, and J. Glatz
Home management of anticoagulation
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q44 - Q49.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
M. Preiss, F. Bernet, and H.-R. Zerkowski
Additional information from the GELIA database: analysis of benefit from self-management of oral anticoagulation (GELIA 6)
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q50 - Q53.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Sidhu and H. O. O'Kane
Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients
Ann. Thorac. Surg., November 1, 2001; 72(5): 1523 - 1527.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R C Tait
Anticoagulation in patients with thromboembolic disease
Thorax, September 1, 2001; 56(90002): ii30 - 37.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Sidhu, H. O'Kane, N. Ali, D. J. Gladstone, M. A.I. Sarsam, G. Campalani, and S. W. MacGowan
Mechanical or bioprosthetic valves in the elderly: a 20-year comparison
Ann. Thorac. Surg., May 1, 2001; 71 (2007): S257 - S260.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
B. G. Macik, J. H. Rand, and B. A. Konkle
Thrombophilia: What's a Practitioner to Do?
Hematology, January 1, 2001; 2001(1): 322 - 338.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Ansell, J. Hirsh, J. Dalen, H. Bussey, D. Anderson, L. Poller, A. Jacobson, D. Deykin, and D. Matchar
Managing Oral Anticoagulant Therapy
Chest, January 1, 2001; 119(1_suppl): 22S - 38S.
[Full Text] [PDF]


Home page
HeartHome page
C van Doorn, R Yates, A Tunstill, and M Elliott
Quality of life in children following mitral valve replacement
Heart, December 1, 2000; 84(6): 643 - 647.
[Abstract] [Full Text]


Home page
ASH Education BookHome page
J. E. Ansell, J. I. Weitz, and A. J. Comerota
Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism
Hematology, January 1, 2000; 2000(1): 266 - 284.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.